Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Part 510
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Final rule.
 SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Phoenix Scientific, Inc., to IVX Animal Health, Inc.  In order to improve the accuracy of the regulations, erroneous entries for Phoenix Pharmaceutical, Inc., are also being removed at this time.
 DATES: This rule is effective November 25, 2005.
 FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: 
                        *david.newkirk@fda.gov*.


SUPPLEMENTARY INFORMATION: Phoenix Scientific, Inc., 3915 South 48th Street Ter., St. Joseph, MO 64503, has informed FDA that it has changed its name to IVX Animal Health, Inc.  Accordingly, the agency is amending the regulations in § 510.600 (21 CFR 510.600) to reflect the change. In addition, FDA has noticed that Phoenix Pharmaceutical, Inc., is no longer a sponsor of an approved new animal drug application.  At this time, § 510.600 is amended to remove entries for this sponsor.  This action is being taken to improve the accuracy of the regulations. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.”  Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects in 21 CFR Part 510 Administrative practice and procedure
Animal drugs
Labeling
Reporting and recordkeeping requirements
 Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows: PART 510—NEW ANIMAL DRUGS
 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority:
                        21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. 2. Section 510.600 is amended in the table in paragraph (c)(1) by removing the entries for “Phoenix Pharmaceutical, Inc.” and “Phoenix Scientific, Inc.”, and by alphabetically adding a new entry for “IVX Animal Health, Inc.”; and in the table in paragraph (c)(2) by removing the entry for “057319” and by revising the entry for “059130” to read as follows: § 510.600
 
 (c)  *     *     * (1)  *     *     * Firm name and address
Drug labeler code*    *    *    *    *IVX Animal Health, Inc., 3915 South 48th Street Ter., St. Joseph, MO 64503
059130*    *    *    *    *
 (2)  *     *     * Drug labeler code
Firm name and address*    *    *    *    *059130
IVX Animal Health, Inc., 3915 South 48th Street Ter., St. Joseph, MO 64503*    *    *    *    *
 Dated: November 15, 2005. Steven D. Vaughn, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.


[FR Doc. 05-23297 Filed 11-23-05; 8:45 am] BILLING CODE 4160-01-S